學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Health View Bioanalytic Limited: Generating Impact from Research
內容大綱
Benny Chung-Ying Zee was a professor at a prestigious university in Hong Kong and founder of Health View Bioanalytic Limited (Health View). Health View offered fast, inexpensive, non-invasive assessments of the risk of stroke and Alzheimer's disease by using artificial intelligence and automatic retinal image analysis (ARIA) of pictures of patients' retinas using fundus cameras. While Health View was breaking even, Zee realized that it was not yet a success. Thus, Zee was considering how to scale up the company to realize the impact of its technology. Zee had to assess the current business model-its value proposition, target market, sales channels, and strategic partners-and determine how he could scale up and redirect Health View.